HC

Healthcare Triangle, Inc.

HCTIHealthcareNASDAQ

Health Information Services · Last scanned Sep 9, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$13.9M
+18.8% YoY
Net Income
-$9.5M
-58.8% YoY
EBITDA
-$8.2M
-112.8% YoY
Free Cash Flow
-$6.4M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3CONFIRMED MACD Positive CrossoverHistogram +0.0045, positive momentum
RSI OversoldRSI 5.0, below 30, stock may be oversold
Aug 25 MACD Negative CrossoverHistogram -0.0191, negative momentum
About Healthcare Triangle, Inc.

Headquartered within the healthcare sector, Healthcare Triangle, Inc. focuses on Health Information Services services and products. Healthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the. Valued at $11.5M, HCTI is a micro-cap name in its sector. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.

Where HCTI stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, HCTI finished 73.38% below its 150-day moving average ($3.08) and 96.43% below its 200-day moving average ($22.96). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is HCTI overbought or oversold?

At the September 3, 2026 close, HCTI's RSI(14) was 5.0, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$11.5M
Fwd P/E-1.01
EPS$-5.78
Beta1.09
52W Change-99.4%
ROE-57.4%
Analysis

Healthcare Triangle, Inc. carries $13.0M in total debt against $2.0M in cash reserves — debt is roughly 6.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$6.4M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -57.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $45.9M (2022) to $13.9M (2025), a 70% decline worth watching.

Healthcare Triangle, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Healthcare Triangle, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms